Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07839884 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time

Name: A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time — clinical trial record (NCT07839884)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 3

SponsorPfizer

Started2026-09-21

View on ClinicalTrials.gov ↗

Pfizer

431 trials monitored

See 32 trials at risk

COPD

1,057 trials monitored

See 28 trials at risk

A Continuation Study of Tilrekimig in Adults with Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About this Medicine when Used for a Long Period of Time.

Trial Details

NCT Number	NCT07839884
Lead Sponsor	Pfizer
Conditions	Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment	1,360 participants
Start Date	2026-09-21
Primary Completion	2034-05-12 (estimated)
Study Completion	2034-05-12 (estimated)
Updated on ClinicalTrials.gov	2026-09-24